Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Epsilon Healthcare Limited ( (AU:EPN) ) has shared an announcement.
Epsilon Healthcare Limited has announced the lodging of an amended Activities Report for the December Quarter 2023 to include disclosures for Related Party Payments and Expenditure, which were initially omitted. This move aims to comply with ASX listing rules. The company is experiencing internal corporate challenges, including disputes among directors, governance issues, and a transition to voluntary administration. Despite these challenges, Epsilon’s manufacturing operations at Southport and Epsilon Clinics have shown positive growth and strong performance.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited (ASX: EPN) is an Australian-based, globally active healthcare organization. The company operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacture, and pharmacy dispensing and information services.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.55M
See more insights into EPN stock on TipRanks’ Stock Analysis page.